Corporate news

Grifols allocates Euros 218 million to dividends, with a compound annual growth rate of 16% over the last 4 years Grifols holds its Ordinary Annual General Shareholders Meeting with more than 80% of its share capital represented
+ info

Grifols Makes Procleix Zika Virus Assay Available for Screening Blood Donations to Countries Accepting CE Mark Grifols strengthens its Procleix portfolio with the CE marking for Procleix Zika Virus Assay
+ info



We are a solid company with an international dimension.

Corporate Commitment

We contribute to improving people's health and wellbeing by offering safe, high quality products produced using the latest environmentally friendly technology.

When a Dream Comes True. An Illustrated History of 75 Years of Grifols

Read When a Dream Comes True: An illustrated history of 75 years of Grifols to discover the company's roots, and learn more about our history and the development of the company.  + info


get to know us better